BiotechTube
Home/Biolojic Design/Neal Curran
NC

Neal Curran

Chief Business Officer

Biolojic Design

Therapeutic Areas

Autoimmune DiseasesImmuno-oncology

Biolojic Design Pipeline

DrugIndicationPhase
TEV '325 (formerly BD9)Atopic Dermatitis, AsthmaPreclinical
Anti-TNFR2 Agonistic AntibodyTherapeutic (Treg modulation)Research/Preclinical

Leadership Team at Biolojic Design

RW
Roger Waltzman
Chief Medical Officer
View full Biolojic Design profile